Table 2.
Results of main outcomes in inflammatory bowel disease patients on low-FODMAP diet
| Number | Week 0 | Week 6 | P value | |
| Irritable Bowel Syndrome-Symptom Severity System (IBS-SSS) | ||||
| Low-FODMAP | 37 | 210 (190-270) | 115 (33-169) | < 0.001 |
| Normal diet | 41 | 245 (180-320) | 170 (91-288) | < 0.001 |
| 0.021 | ||||
| Simple Clinical Colitis Index (SCCAI) | ||||
| Low-FODMAP | 24 | 3 (1-4) | 1 (0-3) | 0.04 |
| Normal diet | 29 | 2 (1-4) | 2 (1-4) | 0.98 |
| 0.021 | ||||
| Harvey and Bradshaw Index (HBI) | ||||
| Low-FODMAP | 9 | 7 (3-8) | 3 (1-5) | 0.05 |
| Normal diet | 12 | 5 (4-11) | 6 (3-9) | 0.25 |
| 0.091 | ||||
| Irritable Bowel Syndrome Quality of Life (IBS-QOL) | ||||
| Low-FODMAP | 36 | 73 (19-99) | 78 (18-99) | < 0.01 |
| Normal diet | 41 | 77 (30-98) | 81 (26-99) | 0.30 |
| 0.091 | ||||
| Short Inflammatory Bowel Disease Questionnaire (SIBDQ) | ||||
| Low-FODMAP | 34 | 47 (42-55) | 60 (51-65) | < 0.01 |
| Normal diet | 40 | 50 (40-57) | 50 (39-60) | 0.54 |
| < 0.011 | ||||
1
P: Mann-Whitney U test comparison of change in outcomes between treatment groups at 6-wk. All data are presented as median (IQR: Interquartile range). P: Wilcoxon signed rank test, comparison of paired samples 0 vs 6-wk for all subjects; All IBS-QOL results on 0-100 scale (0 worst, 100 best).